Hokkaido-Losartan/hydrochlorothiazide Investigation For End Point (H-LIFE study): Multi-center observational study on blood pressure control and cardio- and renoprotective effects of an ARB/ diuretic combination in hypertensive patients in Hokkaido, Japan.
Phase of Trial: Phase IV
Latest Information Update: 12 May 2016
At a glance
- Drugs Losartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms H-LIFE
- 22 Jan 2014 Status changed from active, no longer recruiting to completed, according to University Hospital Medical Information Network - Japan record.
- 22 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 22 Jul 2008 New trial record.